WURSTBAUER KARL
- former member of the university
Publications
26 Publications
2019
Conference papers, proceedings, abstracts
NSCLC stages IIa-IIIc: Tumor related IGRT yields better local control than kV-guidance to anatomic structures
Zehentmayr, F; Karner, J; Wurstbauer, K; Wass, RE; Fastner, G; Rettenbacher, L; Studnicka, M; Pirich, C; Sedlmayer, F; Kopp, P
ANN ONCOL. 2019; 30:
Abstracts (Journal)
2017
Journal Articles
DART-bid for loco-regionally advanced NSCLC
Wurstbauer, K; Zehentmayr, F; Deutschmann, H; Dagn, K; Exeli, AK; Kopp, P; Porsch, P; Maurer, B; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2017; 193(4): 315-323.
Full papers/articles (Journal)
2015
Journal Articles
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr, F; Söhn, M; Exeli, AK; Wurstbauer, K; Tröller, A; Deutschmann, H; Fastner, G; Fussl, C; Steininger, P; Kranzinger, M; Belka, C; Studnicka, M; Sedlmayer, F;
Radiat Oncol. 2015; 10(1): 121
Full papers/articles (Journal)
DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily : High local control in early stage (I/II) non-small-cell lung cancer.
Zehentmayr, F; Wurstbauer, K; Deutschmann, H; Fussl, C; Kopp, P; Dagn, K; Fastner, G; Porsch, P; Studnicka, M; Sedlmayer, F;
Strahlenther Onkol. 2015; 191(3): 256-263.
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
NTCP-Models for Esophagitis with Dose-Differentiated-Radiotherapy (DART-Bid)
Zehentmayr, F; Sohn, M; Exeli, AK; Wurstbauer, K; Troller, A; Deutschmann, H; Fastner, G; Fussl, C; Steininger, P; Kranzinger, M; Belka, C; Studnicak, M; Sedlmayer, F
J THORAC ONCOL. 2015; 10(9): S448-S448.
Abstracts (Journal)
Normal tissue complication models for acute esophagitis in patients treated with accelerated radiotherapy
Zehentmayr, F; Söhn, M; Exeli, AK; Wurstbauer, K; Tröller, A; Fastner, G; Fussl, C; Belka, C; Studnicka, M; Sedlmayer, F;
Radiotherapy and Oncology. 2015; 115(Supplement 1):630-630.-ESTRO 2015; 24.-28.04.2015; Barcelona.
Abstracts (Journal)
2014
Conference papers, proceedings, abstracts
DART - bid (dose-Differentiated Accelerated Radiation Therapy, 1.8 Gy twice daily): An Alternative for the locoregional advanced non-small Lung Cell Cancer (NSCLC)?
Wurstbauer, K; Deutschmann, H; Zehentmayr, F; Fussl, C; Dagn, K; Kopp, P; Porsch, P; Maurer, B; Blaukovitsch, M; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2014; 190: 104-104.
Abstracts (Journal)
2013
Journal Articles
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume
Wurstbauer, K; Deutschmann, H; Dagn, K; Kopp, P; Zehentmayr, F; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
RADIAT ONCOL. 2013; 8:
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
DART - BID (DOSE-DIFFERENTIATED ACCELERATED RADIATION THERAPY, 1.8 GY TWICE DAILY): A NOVEL THERAPEUTIC APPROACH FOR LOCOREGIONALLY ADVANCED, NONRESECTED NON-SMALL CELL LUNG CANCER
Deutschmann, H; Wurstbauer, K; Dagn, K; Zehentmayr, F; Kopp, P; Fussl, C; Porsch, P; Maurer, B; Blaukovitsch, M; Studnicka, M; Sedlmayer, F
J THORAC ONCOL. 2013; 8: S400-S401.
Abstracts (Journal)
Not been operated, non-small cell Lung Cancer (NSCLC): Tumor size - dose-related, accelerated (1.8 Gy BID) Radiotherapy: Final results of a prospective Study
Wurstbauer, K; Deutschmann, H; Dagn, K; Kopp, P; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2013; 189(2): 180-180.
Abstracts (Journal)
2012
Journal Articles
First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Deutschmann, H; Kametriser, G; Steininger, P; Scherer, P; Schöller, H; Gaisberger, C; Mooslechner, M; Mitterlechner, B; Weichenberger, H; Fastner, G; Wurstbauer, K; Jeschke, S; Forstner, R; Sedlmayer, F;
INT J RADIAT ONCOL. 2012; 83(5): 1624-1632.
Full papers/articles (Journal)
The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.
Nawara, C; Rendl, G; Wurstbauer, K; Lackner, B; Rettenbacher, L; Datz, L; Studnicka, M; Sedlmayer, F; Pirich, C;
Q J Nucl Med Mol Imaging. 2012; 56(2): 19-201.
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
NSCLC: RADIATION DOSE - TUMOR SIZE RELATED, ACCELERATED (1,8 GY BID) RADIOTHERAPY - FINAL RESULTS OF A PROSPECTIVE STUDY
Dagn, K; Wurstbauer, K; Deutschmann, H; Kopp, P; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
J THORAC ONCOL. 2012; 7(6): S52-S52.
Abstracts (Journal)
Non-small cell Lung Cancer (NSCLC): Tumor size-dose-correlated, accelerated (1.8 Gy bid) Radiotherapy: Final results of a prospective Study
Wurstbauer, K; Deutschmann, H; Dagn, K; Kopp, P; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2012; 188: 32-33.
Abstracts (Journal)
Nonresected NSCLC: Tumor Size and Radiation Dose in Accelerated (1.8 Gy bid) Therapy - Definitive Results of a Prospective Study
Wurstbauer, K; Deutschmann, H; Dagn, K; Kopp, P; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
INT J RADIAT ONCOL. 2012; 84(3): S589-S589.
Abstracts (Journal)
2010
Journal Articles
Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F;
INT J RADIAT ONCOL. 2010; 77(5): 134-151.
Full papers/articles (Journal)
Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation.
Wurstbauer, K; Weise, H; Deutschmann, H; Kopp, P; Merz, F; Studnicka, M; Nairz, O; Sedlmayer, F;
STRAHLENTHER ONKOL. 2010; 186(10): 551-557.
Full papers/articles (Journal)
2008
Journal Articles
"Augmented reality" in conventional simulation by projection of 3-D structures into 2-D images: a comparison with virtual methods.
Deutschmann, H; Steininger, P; Nairz, O; Kopp, P; Merz, F; Wurstbauer, K; Zehentmayr, F; Fastner, G; Kranzinger, M; Kametriser, G; Kopp, M; Sedlmayer, F;
Strahlenther Onkol. 2008; 184(2):93-99
Full papers/articles (Journal)
A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients.
Nairz, O; Merz, F; Deutschmann, H; Kopp, P; Schöller, H; Zehentmayr, F; Wurstbauer, K; Kametriser, G; Sedlmayer, F;
Strahlenther Onkol. 2008; 184(12):663-667
Full papers/articles (Journal)
2007
Journal Articles
NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F;
STRAHLENTHER ONKOL. 2007; 183 Spec No 2: 38-40.
Full papers/articles (Journal)
2006
Journal Articles
A dosimetric comparison of IORT techniques in limited-stage breast cancer.
Nairz, O; Deutschmann, H; Kopp, M; Wurstbauer, K; Kametriser, G; Fastner, G; Merz, F; Reitsamer, R; Menzel, C; Sedlmayer, F;
STRAHLENTHER ONKOL. 2006; 182(6): 342-348.
Full papers/articles (Journal)
2005
Conference papers, proceedings, abstracts
Accelerated high-dose radiotherapy by target splitting for inoperable non-small cell lung cancer: a phase I trial
Wurstbauer, K; Deutschmann, H; Kopp, P; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F
EJC SUPPL. 2005; 3(2): 333-333.
Abstracts (Journal)
Accelerated high-dose radiotherapy by target splitting for inoperable NSCLC: A phase I trial
Wurstbauer, K; Deutschmann, H; Kopp, P; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F
LUNG CANCER-J IASLC. 2005; 49: S315-S316.
Abstracts (Journal)
2001
Journal Articles
Non-small-cell lung cancer: dose escalation by target splitting with asymmetric collimation.
Wurstbauer, K; Deutschmann, H; Sedlmayer, F; Kogelnik, HD;
Clin Lung Cancer. 2001; 3(2): 151-153.
Full papers/articles (Journal)
Skin markings in external radiotherapy by temporary tattooing with henna: improvement of accuracy and increased patient comfort.
Wurstbauer, K; Sedlmayer, F; Kogelnik, HD;
Int J Radiat Oncol Biol Phys. 2001; 50(1): 179-181.
Full papers/articles (Journal)
1999
Journal Articles
Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
Wurstbauer, K; Deutschmann, H; Kranzinger, M; Merz, F; Rahim, H; Sedlmayer, F; Kogelnik, HD;
Int J Radiat Oncol Biol Phys. 1999; 44(2): 333-341.
Full papers/articles (Journal)